Company / SG&A Expense
BIO-PATH HOLDINGS, INC. SG&A Expense History
FY2012-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$3.4M
FY2018
5-year range
$2.5M / $3.5M
FY2014-FY2018
Trend
-4.1%
vs FY2017
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 7 years, ranging from $986,097 in FY2012 to $4M in FY2017.
Based on SEC 10-K filings.
$3M in FY2018 with a 5-year CAGR of +15.6%.
Increased from $3M to $3M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +11.1%
- 5-Year CAGR
- +15.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +15.6%, indicating consistent growth.
- In FY2018, sg&a expense decreased 4.1% year-over-year.
- Peak sg&a expense was recorded in FY2017.
- Lowest sg&a expense in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -25.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2018 | $3.4M | -4.1% |
| FY2017 | $3.5M | +16.9% |
| FY2016 | $3.0M | +22.3% |
| FY2015 | $2.5M | -9.2% |
| FY2014 | $2.7M | +66.1% |
| FY2013 | $1.6M | +65.8% |
| FY2012 | $986.1K | - |
As of FY2018 · SEC 10-K · Updated Jun 29, 2026